Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Pharmacokinetics and therapeutic efficacy were investigated in patients with multiple myeloma receiving both generic and innovator melphalan (MEL) formulation for conditioning pre autologous stem cell transplantation. Both the MEL formulations were comparable in terms of pharmacokinetics and efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Pai, Aswin Anand, Devasia, Anup J., Panetta, John Carl, Mani, Sathya, Illangeswaran, Raveen Stephen Stallon, Mohanan, Ezhilpavai, Balakrishnan, Balaji, Lakshmi, Kavitha M., Kulkarni, Uday, Aboobacker, Fouzia N., Korula, Anu, Abraham, Aby, Srivastava, Alok, Mathews, Vikram, George, Biju, Balasubramanian, Poonkuzhali
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115908/
https://ncbi.nlm.nih.gov/pubmed/31791694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.08.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados